24 April 2015 in Endoscopy
Background and study aims: Single-operator peroral cholangioscopy enables direct visualization of duct lesions, biopsy, and therapeutic interventions in the biliary and pancreatic ductal systems. The aim of this study was to address the use and outcome of this technology in wider clinical practice. Patients and methods: A nationwide study of endoscopic retrograde cholangiopancreatography (ERCP) procedures, with or without cholangioscopy, was conducted. Procedures that were registered in the Swedish Registry for Gallstone Surgery and ERCP (GallRiks), between 2007 and 2012 were included. The primary outcome was ERCP-specific adverse events. Results: Data from 36 352 ERCP procedures were analyzed, including 408 cholangioscopy procedures. Postprocedural adverse events were more prevalent when cholangioscopy was used (19.1 % vs. 14.0 %). Pancreatitis (7.4 % vs. 3.9 %) and cholangitis (4.4 % vs. 2.7 %) were ERCP-specific adverse events that were elevated in the cholangioscopy group. However, in multivariate analysis, the risks of intraprocedural and postprocedural adverse events were significantly increased in the cholangioscopy group whereas the risks of pancreatitis and cholangitis, when adjusted for confounders, were not. Conclusion: The single-operator peroral cholangioscopy technique is an advanced technique for intraluminal visual inspection, and for therapeutic intervention of the biliary and pancreatic ducts. However, there is a significantly increased risk of intra- and postprocedural adverse events. Thus, this method should preferably be performed at tertiary referral centers in carefully selected patients.
11 April 2016 in United European Gastroenterology Journal
The role of prophylactic pancreatic stenting (PS) in preventing post-endoscopic retrograde cholangio-pancreatography (ERCP) pancreatitis (PEP) has yet to be determined. Most previous studies show beneficial effects in reducing PEP when prophylactic pancreatic stents are used, especially in high-risk ERCP procedures. The present study aimed to address the use of PS in a nationwide register-based study in which the primary outcome was the prophylactic effect of PS in reducing PEP. All ERCP-procedures registered in the nationwide Swedish Registry for Gallstone Surgery and ERCP (GallRiks) between 2006 and 2014 were studied. The primary outcome was PEP but we also studied other peri- and postoperative complication rates. Data from 43,595 ERCP procedures were analyzed. In the subgroup of patients who received PS with a total diameter ≤ 5 Fr, the risk of PEP increased nearly four times compared to those who received PS with a total diameter of >5 Fr (OR 3.58; 95% CI 1.40–11.07). Furthermore, patients who received PS of >5 Fr and >5 cm had a significantly lower pancreatitis frequency compared to those with shorter stents of the same diameter (1.39% vs 15.79%; p = 0.0033). PS with a diameter of >5 Fr and a length of >5 cm seems to have a better protective effect against PEP, compared to shorter and thinner stents. However, in the present version of GallRiks it is not possible to differentiate the exact type of pancreatic stent (apart from material, length and diameter) that has been introduced, so our conclusion must be interpreted with caution.
22 September 2024 in World Journal of Surgery
Background: In South Africa (SA), data on the incidence of thyroid cancer is limited. Papillary thyroid carcinoma is by far the most common malignancy in developed countries; however, a preponderance of follicular thyroid cancer in developing countries, despite iodized salt, has been observed. The aim of this study was to describe the national landscape of thyroid cancer in SA with reference to pathological subtypes, surgical outcomes, and treatments offered.Methods: A multi‐institutional retrospective review of thyroid cancer patients operated on between January 2015 and December 2019 was performed. Public hospitals with associated academic institutions were included. Data were collected from theater registers, pathology, and radiology records. Statistical analysis was done to determine intergroup significance.Results: A total of 464 thyroid cancer cases from 13 centers across five SA provinces were identified. Most patients presented with a mass (67%). Ultrasound was performed in 82% of patients, and 16.3% underwent surgery without pre‐operative cytology. Of the histologically confirmed thyroid cancers, 61.8% were papillary and 22.1% follicular thyroid cancer. There was a significant association between subtype and geographical area, and T‐stage and operation performed. Surgical complication rates included hematoma in 1.8%, post‐operative hypocalcemia in 28.7%, and recurrent laryngeal nerve injury in 3.5%.Conclusion: This first national review describes the landscape of thyroid cancer in SA, revealing considerable differences compared to international studies. It provides valuable insight into the unique South African experience with this disease. In addition, this study serves as an impetus towards a prospective national registry with real‐world data informing contextualized guidelines.
30 September 2021 in Clinical Endoscopy
Background/Aims: Many unanswered questions remain about the treatment of malignant hilar obstruction. We investigated endoscopic stenting for malignant biliary strictures, as reported in a nationwide registry.Methods: All endoscopic retrograde cholangiopancreatography (ERCP) procedures entered in the Swedish Registry of Gallstone Surgery and ERCP from January 2010 to December 2017 in which stenting was performed for malignant biliary stricture management were included in this study. Patency was estimated by determining the time to reintervention.Results: Endoscopic stenting was performed for malignant stricture management in 4623 ERCP procedures, of which 1364 (29.5%) were performed for hilar strictures. Of the hilar strictures, 320 (23.5%) were intrahepatic strictures (Bismuth–Corlette III–IV). Adverse events were more common after hilar stenting than after distal stenting (17.2% vs. 12.0%, p<0.0001). The 6-month reintervention rate was 73.4% after hilar stenting compared with 55.9% after distal stenting (p<0.0001). The 6-month reintervention rates for Bismuth–Corlette types I, II, IIIa, IIIb, and IV were 70.4%, 75.6%, 90.0%, 87.5%, and 85.7%, respectively. In multivariate analysis, the risk for reintervention was three times higher after hilar stenting than after distal stenting (hazard ratio 3.47, 95% confidence interval 2.01–6.00, p<0.001).Conclusions: This study with a relatively large patient cohort undergoing endoscopic stenting confirms that stenting for malignant hilar obstruction has more adverse events and lower patency than stenting for distal malignant obstruction.
20 January 2015 in Endoscopy
FBFrancisco Baldaque-Silva
+1
Endoscopic retrograde cholangiopancreatography (ERCP) is a technically complex endoscopic procedure with significant rates of severe complications (0.8 %) and mortality (0.02 %) [1]. Complication rates increase in those patients where cannulation is difficult, defined as a situation in which the operator using a standard technique fails to achieve cannulation within 5 minutes, makes five unsuccessful attempts, or two passages of the guidewire into the pancreas [2] [3]. Features that are known to be associated with difficult, time-consuming, or impossible cannulations are failure to identify the papilla within the diverticulum, a floppy papilla on the edge of diverticula, and a papilla that is hidden by a mucosal fold ([Fig. 1 a]) [4]. The latter situation can be particularly challenging and has few possible solutions [5]. We hereby describe the first two patients in which we used an endoclip and a snare to lift the mucosal fold and allow access to a hidden papilla. The first patient was a 70-year-old woman with a bile leak after hemihepatectomy. She had a flat papilla, underneath a floppy mucosal fold, that could not be cannulated. The second patient was a 55-year-old woman with a post-cholecystectomy bile leak. She had a papilla that was hidden behind a fold and had undergone two ERCPs and a precut sphincterotomy because of unsuccessful bile duct cannulation. In both patients an endoclip (Resolution Clip; Boston Scientific Corporation, Natick, Massachusetts, USA) was placed on the fold. The duodenoscope was withdrawn and was then re-introduced with a biopsy forceps inside the working channel that was used to grasp a polypectomy snare (Sensation Short Throw, 13 mm; Boston Scientific) so that this was introduced beside the scope. The snare loop was then tightened slightly around the shaft of the endoclip ([Fig. 1 b]) and the wire was pulled up through the mouth ([Fig. 1 c]), which slightly altered the alignment of the papillary region, so allowing the opening of the papilla to be visualized ([Fig. 1 d]) and successfully cannulated. These are the first successful cases of clip and snare-assisted cannulation, a way of accessing the bile duct in otherwise apparently impossible conditions, by either pulling or pushing ([Fig. 2]) a snared clip that had been previously positioned on the mucosal fold that was hiding the papilla. Endoscopy_UCTN_Code_TTT_1AR_2AB